Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0759 in Postherpetic Neuralgia
NCT00245544Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Nov 2005
- Primary completion
- Jan 2007
01
Overview
A Phase 2 trial of MK-0759 in postherpetic neuralgia (PHN), sponsored by Merck & Co.. Started Nov 2005; status: terminated.
02
Drugs
MK-0759
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00245544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245544.